Cost-effectiveness of consolidation treatments for acute myeloid leukemia in high-risk pediatric patients within the Colombian healthcare system
Abstract
Introduction: Acute myeloid leukemia represents about 20% of leukemias in minors under 18 years old. At present, there are only two consolidation treatment alternatives: Chemotherapy and stem-cell transplantation.
Objective: To evaluate the cost-effectiveness of unrelated and related hematopoietic stem cell transplantations, versus chemotherapy consolidation in pediatric patients with high-risk acute myeloid leukemia.
Materials and methods: A decision tree was constructed with life-years gained as the outcome. Costs and probabilities were extracted from the literature. Probabilistic sensitivity analyses and acceptability curves were computed. The cost-effectiveness threshold was three times the 2010 per capita gross domestic product.
Results: When compared to consolidation chemotherapy cycles, related and unrelated hematopoietic stem-cell transplantation had incremental cost-effectiveness ratios of COP$ 9,226,421 (USD$ 4,820) and COP$ 6,544,116 (USD$ 3,419) respectively, which are lower than the per capita gross domestic product (COP$ 12,047,418, USD$ 6,294). Transplant proved to be cost-effective in 70% of the simulations and had a higher probability of the willingness to pay being over than COP$ 7,200,000 (USD$ 3,762).
Conclusion: In Colombia, related and unrelated hematopoietic stem-cell transplants are cost-effective alternatives to consolidation treatment for high-risk acute myeloid leukemia in pediatric patients.
Downloads
Some similar items:
- Patricia Escobar, Katherine Paola Luna, Indira Paola Hernández, César Mauricio Rueda, María Magdalena Zorro, Simon L. Croft, In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole , Biomedica: Vol. 29 No. 3 (2009)
- Gerzaín Rodríguez, Rafael Pinto, Fernando López, Yenny Gómez, Persistent type 2 lepra reaction and clofazimine-induced lethal enteropaty , Biomedica: Vol. 29 No. 1 (2009)
- Flor de María Cáceres, Luis Carlos Orozco, Incidence of and factors for non-compliance to antituberculous treatment , Biomedica: Vol. 27 No. 4 (2007)
- Lyda Osorio, Ligia del Pilar Pérez, Iveth J. González, Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin , Biomedica: Vol. 27 No. 1 (2007)
- Paula Ximena Pavía, Nubia Lucía Roa, Ana María Uribe, Concepción Judith Puerta, Using S35-S36 and TcH2AF-R primer-based PCR tests to follow-up a Chagas’ disease patient who had undergone a heart transplant , Biomedica: Vol. 31 No. 2 (2011)
- John F. Arboleda, Luis F. García, Cristiam M. Álvarez, ILT3+/ILT4+ tolerogenic dendritic cells and their influence on allograft survival , Biomedica: Vol. 31 No. 2 (2011)
- Yazmin Rocío Arias, Karime Osorio-Arango, Brayan Bayona, Guadalupe Ercilla, Mauricio Beltrán-Durán, Determination of HLA-A, -B and -DRB1 polymorphism in brain dead organ donors representative of the Colombian general population, 2007-2014 , Biomedica: Vol. 37 No. 2 (2017)
- Laura Plata-Casas, Óscar Gutiérrez-Lesmes, Óscar Herrán-Falla, Tuberculosis and human immunodeficiency virus coinfection: Epidemiological situation in the department of Meta, 2010- 2015 , Biomedica: Vol. 38 No. Sup. 2 (2018): Suplemento 2, Medicina tropical
- María Elena Mejía-Rojas , Adolfo Contreras-Rengifo, Mauricio Hernández-Carrillo , Quality of life in women treated with chemotherapy for breast cancer in Cali, Colombia , Biomedica: Vol. 40 No. 2 (2020)
- Lina Echeverri-Toro, Andrés Arango, Sigifredo Ospina, Carlos Agudelo, Bordetella bronchiseptica recurrent bacteraemia in a patient with bone marrow transplantation , Biomedica: Vol. 35 No. 3 (2015)
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |